51 – 60 of 139
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection
(
- Contribution to journal › Scientific review
- 2012
-
Mark
Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y12 receptor-mediated platelet aggregation.
(
- Contribution to journal › Article
-
Mark
Factor VIIa binding to endothelial cell protein C receptor: Differences between mouse and human systems
(
- Contribution to journal › Article
-
Mark
Small and large PROS1 deletions but no other types of rearrangements detected in patents with protein S deficiency
(
- Contribution to journal › Article
-
Mark
Translational platelet research in patients with coronary artery disease: hat are the rnalor knowledge gaps?
(
- Contribution to journal › Scientific review
-
Mark
Management consensus guidance for the use of rivaroxaban - an oral, direct factor Xa inhibitor
(
- Contribution to journal › Article
- 2011
-
Mark
Modern treatment options for von Willebrand disease and haemophilia B - What are the benefits for the patients?
(
- Contribution to journal › Article
-
Mark
A large deletion identified in a Swedish family with type 1 VWD
(
- Contribution to journal › Letter
-
Mark
Inhibitors in haemophilia A - Prevention, current management and personalised therapy perspectives
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Binding characteristics of thrombin-activatable fibrinolysis inhibitor to streptococcal surface collagen-like proteins A and B
(
- Contribution to journal › Article